Immunity Passport
COVID-19
Create your own Immunity Passport with Testing and PPE
Recommendations from
Dr. Elaine Chin, Personalized Medicine Expert
Asymptomatic Spread is Real
I think I’m infected with COVID-19 now
If I become sick and suspect
I’ve been infected
I need to get tested
Know if you have an active virus in your body by finding RNA pieces OR antigen proteins of the virus using a swab.
Knowing if you have antibodies is an alternative to getting a nasal swab, especially when it’s not accessible to you.
Antibodies will be able to determine if you are still infectious or recently infected.
When testing is done early, IgM antibodies appear days after exposure to the coronavirus and could last for up to fourteen days. As you recover, IgG antibodies will appear and IgM antibodies will disappear.
Maybe I had COVID-19 in the recent past
Now that I’ve recovered from a
possible COVID-19 infection
I need to know if
I’ve developed immunity
Know if you have immunity by evaluating the level of IgG antibodies in your blood.
Once recovery begins, your IgM antibodies will be less detectable and IgG antibodies will become more predominant. The presence of IgG antibodies may infer immunity for a few months.
So why should I get tested if antibodies may become undetectable? If you’ve been exposed to COVID-19 you may be at risk of developing Post COVID-19 symptoms such as shortness of breath (fibrosis of the lungs), chest pain (heart valve damage and artery disease), brain fog mini-stroke), headaches, chronic rash, and fatigue.
Spreaders are most contagious the first 3 days of a COVID-19 infection when asymptomatic.
Some people remain asymptomatic throughout their COVID-19 illness. W.H.O. sets it round 40%.
Temperature checks and questionnaires are inadequate for screening silent spreaders.
Testing is the only way to detect and keep control of virus
RAPID COVID-19 DETECTION Tests Approved in Canada
Because of its ease of use and portability of rapid tests, it has the potential of providing frontline healthcare workers, workplaces, and schools with a tool that they have been in need of since the start of the COVID-19 pandemic.
Rapid tests MUST NOW be an immediate part equation along with high-volume lab-based tests to identify patients with active infections. The Abbott System (USA) and SD Biosensor (South Korea) tests are both FDA approved CLIA-waived tests, which means that the technology can be used in settings outside the traditional hospital setting.
As of October, Canada has approved two platform based COVID-19 detection tests. Both are DNA “PCR tests”. Pending still are antigen-based tests such as the SD Biosensor cartridge system. Both the Abbott and SD Biosensor tests have been approved for use by the World Health Organization.
WHO Director General, Tedros Adhanom Ghebreyesus, said the manufacturers Abbott and SD Biosensor had agreed with the Bill & Melinda Gates Foundation to “make 120 million of these new, highly portable and easy-to-use rapid COVID-19 diagnostic tests available over a period of six months”.
About the SD Biosensor Test System
The SD Biosensor test is simpler and easier to use than the ABBOTT system because it does not require a ID NOW device. It can be administered by healthcare professionals but if necessary, can be self-administered in the safety and comfort of one’s workplace or home.
About the SD Biosensor Test System
Abbott ID NOW is one of the most widely available molecular point-of-care testing technologies in use in the U.S. Since its introduction in 2014, it has been used in physicians’ offices and urgent care centers to rapidly detect influenzas A & B, strep A, and respiratory syncytial virus (RSV). And now, it’s able to detect COVID-19.
NO test is always 100% sensitive because it depends on three main variables:
- Technique for sampling
- Stage of infection – which impacts viral load
- Type of test
However, RAPID tests are important and necessary added tools in our effort to do more testing and most importantly get results that people can act on, on the advice of health care professionals.
Take personal control of your health and protect your family with a simple at home self-test kit for COVID-19 antibodies.
What to Expect?
At Home Self-Testing Kit
Understand your current state of IgG and IgM antibodies for COVID-19 using a self-administered test kit in the safety and comfort of your home.
CLIA Approved Lab
Blood spot sample is processed by a CLIA approved lab (USA) using a Roche platform that is FDA approved under EUA.
Accurate and Reliable Test
Unlike some unreliable rapid tests, this lab-based test is accurate with a high specificity (99.8%) and sensitivity (100%) by day 14.
Get Results Online Quickly
Once your sample arrives at the lab, expect to get your results online within 48-72 hours in a secure health portal.
No Vaccine is on the Horizon
A vaccine is unlikely to appear in the next 6 to 12 months.
If one becomes available, it could be less than 50% effective like some flu shots.
There’s no vaccine for SARS coronavirus because it mutated often. The COVID-19 virus has mutated over 250 times so far.
Therefore, protection from airborne and surface risks are critical.
Voice Cloud
Talking can launch thousands of droplets in the air for 8-14 minutes. They are so small that any slight fluctuation in the air currents help keep airborne for hours. Somebody nearby can inhale droplets and become infected despite of social distancing.
Airborne Factors
When social distancing is not possible or simply not good enough, masks are critical. Level 1 medical masks are far superior to cloth masks. And if cloth masks are used, it needs to be 3-ply made with three materials per W.H.O.
Surface Lifespan
The Covid-19 virus can live for hours in the air and up to 3 days on some surfaces. This virus waits to enter a live host to replicate. Hence, it’s important to use appropriate cleansers and disinfectants that are Health Canada or equivalent approved.
COVID-19 Remains a Threat
We are only at the beginning of flattening the curve in Canada.
Most vulnerable are certainly older (age 60+). Of the 5% who needed hospitalization, 96% had pre-existing chronic conditions of cardiovascular disease, diabetes, hypertension, etc. Obesity remains a predisposition for all these conditions.
Waves Two and Three: Summer/Fall 2020 and Winter 2021.
